Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.

Abstract

BACKGROUND The Dialysis Access Consortium (DAC) was developed to investigate interventions to improve hemodialysis vascular access outcomes. The autogenous arteriovenous fistula created by direct connection of native artery to vein is the recommended vascular access for hemodialysis. However, it fails frequently due to clotting after surgery. PURPOSE The… (More)

Topics

Cite this paper

@article{Dember2005DesignOT, title={Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.}, author={Laura M Dember and James S. Kaufman and Gerald J. Beck and Bradley Dixon and Jennifer J. Gassman and Tom Greene and Jonathan Himmelfarb and Lawrence G. Hunsicker and John Walter Kusek and J. Lawson and John Paul Middleton and Milena Radeva and Steve J. Schwab and James F Whiting and Harold I. Feldman}, journal={Clinical trials}, year={2005}, volume={2 5}, pages={413-22} }